AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Sampre Nutritions Limited

₹6.1 -$19.87 (-76.51%)
BSE · 16 Sep 2026 07:37 UTC
Previous Close
₹6.29
Day Range
₹5.98₹6.45
Year Range
₹4.51₹42.33
Market Cap
579.55M
AVG Volume
360.18K
Trailing/Forward PE
15.24/-
PEG ratio
0.08
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Bombay Stock ExchangeIN
Revenue (INR) · TTM
0200M400M600M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
SAMPRE.BO Revenue (INR) · TTM by quarter
PeriodRevenue (INR) · TTM
27 Q1473.29M
26 Q4433.37M
26 Q3360.04M
26 Q2341.97M
26 Q1314.69M
25 Q4251.24M
25 Q3221.23M
25 Q2235.38M
25 Q1222.26M
24 Q4251.47M
Net Income (INR) · TTM
-100M-50M050M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
SAMPRE.BO Net Income (INR) · TTM by quarter
PeriodNet Income (INR) · TTM
27 Q135.62M
26 Q435.67M
26 Q3-51.32M
26 Q2-62.92M
26 Q1-70.64M
25 Q4-76.72M
25 Q31.53M
25 Q28.94M
25 Q111.26M
24 Q42.32M
Operating Income (INR) · TTM
-50M-25M025M50M75M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
SAMPRE.BO Operating Income (INR) · TTM by quarter
PeriodOperating Income (INR) · TTM
27 Q151.21M
26 Q427.12M
26 Q3-36.26M
26 Q2-28.69M
26 Q1-36.39M
25 Q4-40.92M
25 Q339.61M
25 Q228.87M
25 Q131.61M
24 Q423.22M
EBITDA (INR) · TTM
-50M-25M025M50M75M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
SAMPRE.BO EBITDA (INR) · TTM by quarter
PeriodEBITDA (INR) · TTM
27 Q152.82M
26 Q451.9M
26 Q3-11.11M
26 Q2-21.18M
26 Q1-30.69M
25 Q4-34.97M
25 Q345.71M
25 Q250.66M
25 Q152.09M
24 Q442.24M
EPS (INR) · TTM
-1.5-1-0.500.524 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
SAMPRE.BO EPS (INR) · TTM by quarter
PeriodEPS (INR) · TTM
27 Q10.4
26 Q40.41
26 Q3-0.77
26 Q2-0.91
26 Q1-0.98
25 Q4-1.03
25 Q30.11
25 Q20.21
25 Q10.28
24 Q4-0.04
Expenses (INR) · TTM
025M50M75M100M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
SAMPRE.BO Expenses (INR) · TTM by quarter
PeriodExpenses (INR) · TTM
27 Q183.61M
26 Q432.62M
26 Q337.21M
26 Q262.53M
26 Q162.53M
25 Q462.53M
25 Q361.63M
25 Q260.76M
25 Q160.76M
24 Q460.76M
PE Ratio
0100200300400med 27.21Jan 25Feb 25Apr 25May 25Jun 25Aug 26Sep 26
SAMPRE.BO PE Ratio by quarter
PeriodPE Ratio
Sep 2615.41
Sep 2615.19
Sep 2616.24
Aug 2613.23
Aug 2613.96
Aug 2613.74
Aug 2613.11
Jul 2612.05
Jul 2615.48
Jul 2618.2
Jul 2614.31
Jul 2618.64
Jun 25398.31
Jun 25361.03
Jun 25300.15
Jun 25285.99
May 25318.56
May 25314.31
May 25307.7
May 25278.91
May 25308.17
Apr 25333.19
Apr 25361.03
Apr 25334.13
Apr 25294.49
Mar 2517.36
Mar 2520.43
Mar 2521.32
Mar 2524.23
Feb 2527.05
Feb 2527.45
Feb 2526.34
Feb 2527.36
Feb 2526.09
Jan 2532
Jan 2540.58
Jan 2542.19
Jan 2547.63
Price to Sales
051015med 3.44Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26
SAMPRE.BO Price to Sales by quarter
PeriodPrice to Sales
Sep 261.27
Sep 261.25
Sep 261.34
Aug 261.09
Aug 261.15
Aug 261.13
Aug 261.08
Jul 260.99
Jul 261.27
Jul 261.5
Jul 261.18
Jul 261.53
Jun 262.24
Jun 262.32
Jun 262.99
Jun 263.29
May 263.74
May 263.79
May 264.16
May 265.04
Apr 264.96
Apr 265.36
Apr 264.9
Apr 264.76
Apr 264.86
Mar 264.66
Mar 265.59
Mar 265.65
Mar 264.85
Feb 265.61
Feb 265.2
Feb 265.68
Feb 266.22
Feb 266.1
Jan 265.78
Jan 266.05
Jan 266.44
Jan 266.67
Dec 256.33
Dec 256.68
Dec 257.66
Dec 257.33
Nov 258.54
Nov 257.84
Nov 259.81
Nov 259.17
Oct 259.93
Oct 2510.98
Oct 2510.15
Oct 259.2
Oct 258.34
Sep 258.38
Sep 257.59
Sep 256.88
Sep 256.23
Aug 255.65
Aug 255.22
Aug 254.73
Aug 254.37
Aug 253.96
Jul 253.59
Jul 253.25
Jul 252.95
Jul 252.68
Jun 252.76
Jun 252.5
Jun 252.08
Jun 251.98
May 252.2
May 252.18
May 252.13
May 251.93
May 252.13
Apr 252.31
Apr 252.5
Apr 252.31
Apr 252.04
Mar 250.66
Mar 250.78
Mar 250.81
Mar 250.92
Feb 251.03
Feb 251.04
Feb 251
Feb 251.04
Feb 250.99
Jan 251.22
Jan 251.54
Jan 251.6
Jan 251.81
EV/EBITDA
57.51012.51517.5med 10.82Jan 25Feb 25Apr 25May 25Jun 25Aug 26Sep 26
SAMPRE.BO EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2614.03
Sep 2613.87
Sep 2614.6
Aug 2612.53
Aug 2613.03
Aug 2612.88
Aug 2612.44
Jul 2611.72
Jul 2614.08
Jul 2615.94
Jul 2613.27
Jul 2616.25
Jun 2513.34
Jun 2512.09
Jun 2510.05
Jun 259.58
May 2510.67
May 2510.53
May 2510.31
May 259.34
May 2510.32
Apr 2511.16
Apr 2512.09
Apr 2511.19
Apr 259.86
Mar 256.58
Mar 257.12
Mar 257.28
Mar 257.79
Feb 258.29
Feb 258.36
Feb 258.16
Feb 258.34
Feb 258.12
Jan 259.16
Jan 2510.67
Jan 2510.96
Jan 2511.92
Price to Book
01234med 1.68Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26
SAMPRE.BO Price to Book by quarter
PeriodPrice to Book
Sep 260.51
Sep 260.5
Sep 260.54
Aug 260.44
Aug 260.46
Aug 260.46
Aug 260.44
Jul 260.4
Jul 260.51
Jul 260.6
Jul 260.48
Jul 260.62
Jun 260.82
Jun 260.85
Jun 261.1
Jun 261.21
May 261.38
May 261.39
May 261.53
May 261.85
Apr 261.82
Apr 261.97
Apr 261.8
Apr 261.75
Apr 261.79
Mar 261.63
Mar 261.95
Mar 261.97
Mar 261.69
Feb 261.96
Feb 261.81
Feb 261.98
Feb 262.17
Feb 262.13
Jan 262.02
Jan 262.11
Jan 262.25
Jan 262.33
Dec 252.19
Dec 252.31
Dec 252.65
Dec 252.54
Nov 252.96
Nov 252.72
Nov 253.4
Nov 253.17
Oct 253.44
Oct 253.8
Oct 253.51
Oct 253.19
Oct 252.89
Sep 252.32
Sep 252.1
Sep 251.9
Sep 251.72
Aug 251.56
Aug 251.44
Aug 251.31
Aug 251.21
Aug 251.09
Jul 250.99
Jul 250.9
Jul 250.81
Jul 250.74
Jun 252.26
Jun 252.05
Jun 251.7
Jun 251.62
May 251.81
May 251.78
May 251.74
May 251.58
May 251.75
Apr 251.89
Apr 252.05
Apr 251.89
Apr 251.67
Mar 250.57
Mar 250.68
Mar 250.71
Mar 250.8
Feb 250.9
Feb 250.91
Feb 250.87
Feb 250.91
Feb 250.86
Jan 251.06
Jan 251.34
Jan 251.4
Jan 251.58
Sampre Nutritions Limited
SAMPRE.BO
Stockpicker

Video analysis: SAMPRE.BO

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.